Numerous UT MD Anderson Meet the Experts sessions are scheduled throughout ESMO.
Friday, October 23 (All times in CEST)
13:30–14:00 (1:30–2 p.m.)
Defining the future of breast cancer care
Carlos Barcenas, M.D.
Professor, Breast Medical Oncology
16:00-17:00 (4-5 p.m.)
The next generation of immunotherapies
Stéphane Champiat, M.D., Ph.D.
Associate Professor, Investigational Cancer Therapeutics
Saturday, October 24 (All times in CEST)
11:00–12:00 (11 a.m.–12 p.m.)
Patient-centered palliative care
David Hui, M.D.
Professor, Palliative Care and Rehabilitation Medicine
11:30–12:00 (11:30–12 p.m.)
Decoding the latest leukemia advances, Part 1
Courtney DiNardo, M.D.
Professor, Leukemia
13:00–13:30 (1–1:30 p.m.)
Clinical trials at UT MD Anderson
Jennifer Litton, M.D.
Chief Clinical Research Officer
Sunday, October 25 (All times in CET)
10:15–10:45 (10:15–10:45 a.m.)
Transforming outcomes in genitourinary cancers
Omar Alhalabi, M.D.
Associate Professor, Genitourinary Medical Oncology
Andrew Hahn, M.D.
Assistant Professor, Genitourinary Medical Oncology
Andrew Johns, M.D.
Assistant Professor, Genitourinary Medical Oncology
11:00–11:30 (11–11:30 a.m.)
Accelerating discoveries with industry partnerships
Emily Barnhill
Vice President, Strategic Industry Ventures
13:00–13:30 (1–1:30 p.m.)
From target to therapy: Advances in drug discovery
Tim Heffernan, Ph.D.
Vice President and Head of R&D, Therapeutics Discovery
Timothy Yap, M.B.B.S., Ph.D.
Vice President, Head of Clinical Development, Therapeutics Discovery Division
Professor, Department of Investigational Cancer Therapeutics
Monday, October 26 (All times in CET)
11:30–12:00 (11:30–12 p.m.)
Decoding the latest leukemia advances, Part 2
Musa Yilmaz, M.D.
Associate Professor, Leukemia
12:00–12:30 (12–12:30 p.m.)
Translating genomic discovery into clinical impact
Andy Futreal, Ph.D.
Chair, Genomic Medicine
Jordi Rodón, M.D., Ph.D.
Professor, Investigational Cancer Therapeutics